Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study - Seite 3

^{1 Alzheimer’s disease facts and figures. Alzheimer’s Disease and Dementia. (n.d.). https://www.alz.org/alzheimers-dementia/facts-figures#:~:text=More%20t ...’s,are%20age%2075%20or%20older}

View source version on businesswire.com: https://www.businesswire.com/news/home/20240417265912/en/

The Hyperfine Registered (A) Stock at the time of publication of the news with a fall of -1,49 % to 0,990USD on Nasdaq stock exchange (17. April 2024, 02:00 Uhr).